
ARA-290
ARA-290 (cibinetide) is an 11-amino-acid peptide built from erythropoietin. Each kit is 10 vials of 10 mg from one batch.
10 vials from one batchFreeze-dried powder4.8 on Trustpilot
Also known as Cibinetide, pHBSP
For research and laboratory use only. Not for human consumption.
- Batch
- Delivery
- Free tracked shipping to 150+ countries. Delivery guaranteed. How delivery works
- Report
- Batch report after the first test · Delivery photos
- Guarantee
- Once this compound's first Certificate of Analysis is published at /lab-results, the same below-COA-purity reship guarantee applies.
- Help
- A person answers on WhatsApp, even at 3 a.m. your time.
ARA-290: Key Facts
ARA-290 is a healing recovery research peptide supplied by LyzeLabs as a lyophilized reference standard, strictly for laboratory research use. It is available in 1 format. Batch certificates of analysis are published on the lab-results page as verification completes.
| Compound | ARA-290 |
|---|---|
| Research category | Recovery |
| Available formats | 10mg*10vials |
| Strength shown | 10 mg |
| Molecular formula | C₅₁H₈₄N₁₆O₂₁ |
| Molecular weight | 1257.3 g/mol |
| CAS number | 1208243-50-8 |
| Purity | Published on the lab-results page as verification completes |
| Test method | HPLC + mass spectrometry |
| Certificate of analysis | Published on the lab-results page after the first test |
| Intended use | Laboratory research use only. Not for human consumption. |
| Handling | Supplied lyophilized, store per the stability guide |
Good to know
All ten vials are from one batch. One batch report covers the whole kit, so the first vial matches the last.
Your price drops with every kit. Any mix counts, up to 42% off at 50 kits.
About This Product
What is ARA-290?
ARA-290 is a short peptide of 11 amino acids, copied from one face of erythropoietin (EPO), the hormone that tells the body to make red blood cells. Its drug name is cibinetide.
EPO also protects tissue under stress. ARA-290 keeps that protective signal and drops the blood-making one, so it does not raise red blood cell counts.
How does ARA-290 work?
- Protective receptor: it binds a receptor made of two parts, the EPO receptor and the beta-common receptor (CD131).
- Calmer inflammation: in studies, it lowered inflammation signals in hurt tissue.
- No extra red cells: it skips the receptor that makes red blood cells.
What do researchers study it for?
- Small-fiber nerve damage and nerve pain
- Kidney injury
- Stroke and brain protection
- Inflammation and autoimmune models
Key studies
- Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain (Invest Ophthalmol Vis Sci, 2017). Small nerve fibers grew back in the cornea and the skin.
- ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes (Mol Med, 2015). HbA1c, blood fats and nerve pain scores improved over 56 days.
- ARA290, a non-erythropoietic EPO derivative, attenuates renal ischemia/reperfusion injury (J Transl Med, 2013). Better kidney function and less scarring after injury.
- Erythropoietin-derived peptide ARA290 mediates brain tissue protection through the β-common receptor in mice with cerebral ischemic stroke (CNS Neurosci Ther, 2024). Brain protection after stroke in mice, through the beta-common receptor, without making red cells.
Status (November 2026)
Investigational; not an approved medicine.
Quality Standards
- Form: freeze-dried powder in sealed vials
- Storage: refrigerator for near-term use, minus 20 degrees Celsius long-term
- Batch report: goes up on /lab-results once testing of the first batch is complete
Related research
For research purposes only. Not for human consumption or therapeutic use.
Research Context for ARA-290
Tissue Repair and Recovery Research Context
Healing and recovery peptides are studied across tendon, muscle, nerve, vascular, and gastrointestinal models. Research in this category focuses on angiogenesis, cell migration, growth factor signaling, and the kinetics of repair under controlled conditions. Reproducibility depends heavily on batch consistency and reliable analytical verification.
ARA-290 ships as a lyophilized research reagent through the LyzeLabs™ catalog in the Recovery category, available as a single research-grade format. Verified LyzeLabs compounds publish their full HPLC chromatogram and mass spectrometry confirmation for each batch on the LyzeLabs lab results page; this compound's analytical data is published there as it completes verification.
Related Research Guides
Other Compounds in the Recovery Category
Research Tools for This Compound
Frequently Asked Questions
Is ARA-290 the same as cibinetide?
Yes. ARA-290 is the research name and cibinetide the drug name. It is also called pHBSP, for pyroglutamate helix B surface peptide.
Does ARA-290 raise red blood cells?
No. It was built from the part of EPO that protects tissue, not the part that makes red blood cells, and studies report no rise in red cells.
ARA-290 vs EPO: what is the difference?
EPO is a large hormone that makes red blood cells and also protects tissue. ARA-290 is an 11-amino-acid piece that keeps the protective signal only.
Is ARA-290 approved?
No. As of November 2026 it is investigational. The ARA-290 sold here is research material for laboratory use only.
What comes in a ARA-290 kit?
Ten sealed vials of freeze-dried ARA-290, all from one batch, at 10 mg a vial.
How should ARA-290 be stored?
Keep the sealed vials at -20°C. Once mixed, keep it at 2 to 8°C and use it within 14 days.
How does ARA-290 ship?
ARA-290 ships as a freeze-dried powder in sealed vials, which stays stable at room temperature for the trip. Every order goes out in plain packaging with tracking, and most arrive in 7 to 14 days. Store it in the freezer at -20°C once it arrives.
1 kit
$275